MedTrace Logo

An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial (MTN-003)

NCT02358616 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 219

Last updated 2021-06-23

No results posted yet for this study

Summary

This study is primarily exploratory and is designed to both identify factors that may have affected participant adherence to study product in VOICE, and describe how sexual behaviors, such as anal sex, may have had an effect on product efficacy. As such there is no specific hypothesis that is being tested.

Conditions

  • HIV Prevention

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Microbicide Trials Network

    lead NETWORK

Principal Investigators

  • Ariane van der Straten, PhD · RTI International

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • South Africa
  • Uganda
  • Zimbabwe

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02358616 on ClinicalTrials.gov